Pathological Changes of Amyotrophic Lateral Sclerosis with in Vivo Magnetic Resonance Spectrum and Diffusion Tensor Imagings

Hong YIN,Jian ZHANG,Lin MA,Qian-shi LING,De-jun LI,Yuan-gui GAO
DOI: https://doi.org/10.3760/cma.j.issn.1671-8925.2006.10.006
2006-01-01
Abstract:Objective To detect the patholgical changes of amyotrophic lateral sclerosis (ALS) with magnetic resonance spectrum imaging (MRSI), diffusion tensor imaging (DTI) and magnetic resonance imaging (MRI), to compare their differences and values in the diagnosis of ALS. Methods Twelve ALS patients were compared to 12 normal controls. Fractional anisotropy (FA) and mean diffusivity (MD) were measured at various locations in the corticospinal tract (CST), including the subcortical white matter (SWM), centrum semiovale (CS), periventricular white matter (PV), posterior limb of the internal capsule (PIC) and cerebral peduncle (CP), and the ratio of N-acetyl-asparte (NAA) to creatine (Cr) were measured at SWM, PV and PIC. Results ALS showed significantly lower FA than controls in the CST, including the SWM, CS, PV and PIC (P0.001). Although there was a trend towards elevated MD in ALS, this did not reach statistical significance. NAA/Cr ratios were also decreased in ALS compared to normal controls (P0.05), with significant differences at the SWM and PV but not in PIC. The T1WI, T2WI, FLAIR of ALS and normal control groups showed that there was no significant difference on MRI between the 2 groups. Conclusion The combination of whole-brain DTI and MRSI can in vivo detect axonal degeneration along CST in ALS patients. Measurements of FA in the SWM, CS, PV and PIC, and NAA/Cr ratios in the SWM and PV can offer the most powerful clues. The MRI changes can not tell ALS from normal control.
What problem does this paper attempt to address?